Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today a settlement and license agreement with ...

BRIDGEWATER, N.J. and BENGALURU, Karnataka, India, April 15, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application for EYLEA HD Injection 8 mg. The sBLA seeks ...

BENGALURU: Biopharmaceutical company Biocon's share price on Tuesday jumped over 4 per cent after its subsidiary Biocon ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $831.43, with a high estimate of $1013.00 and a low estimate of $547.00. Highlighting a 8.86% ...

Biocon Biologics announced a major milestone in its US expansion plans, inking a settlement and licensing agreement with ...

ZORBAX Rapid Resolution columns have high efficiency in both short and ultra-short column lengths. Rapid Resolution columns are available in analytical and narrow-bore id. ZORBAX Rapid Resolution ...

The resolution of the external display is reportedly 2088 x 1422 pixels (13 mini: 2340 x 1080). The main screen is said to reach 7.76 inches, which would be slightly less than the previously ...

In the pursuit of the extraordinary, the novel, and the unexpected, science and math at RIT blends a passion for research, the practical application of theory, and the active pursuit of new ...

With over 15 years of testing and reviewing headphones and earbuds, our expert team knows exactly what sets the best models apart – whether it's outstanding audio quality, smart features ...